Is preoperative RAS or BRAF K601E mutations cytologic detection useful for clinical management of indeterminate thyroid nodules, according to the new WHO classification?

导出原文传递

翻译打印收藏纠错

作者： Ravella, L. ^[1] ; Lopez, J. ^[2] ; Descotes, F. ^[3] ; Giai, J. ^[4] ; Lapras, V. ^[5] ; Denier, M. ^[6] ; Borson-Chazot, F. ^[7] ; Lifante, J. ^[8] ; Decaussin-Petrucci, M.

作者单位： Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Biochem, Mol Biol, Pierre Benite, France ^[1] CNRS, UMR 5558, Lab Biometrie & Biol Evolut, Equipe Biostat Sante, Villeurbanne, France ^[2] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Endocrine Surg, Pierre Benite, France ^[3] Hosp Civils Lyon, Grp Hosp Est, Dept Endocrinol, Bron, France ^[4] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Pathol, Pierre Benite, France ^[5] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Radiol, Pierre Benite, France ^[6] Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Pathol, Pierre Benite, France ^[7] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Biochem & Mol Biol Dept, Pierre Benite, France ^[8]

发布时间 2020-08-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Virchows Archiv

2019年475卷Suppl.1期

S23-S23页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Is preoperative RAS or BRAF K601E mutations cytologic detection useful for clinical management of indeterminate thyroid nodules, according to the new WHO classification?

Virchows Archiv

相似文献

Virchows Archiv

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Is preoperative RAS or BRAF K601E mutations cytologic detection useful for clinical management of indeterminate thyroid nodules, according to the new WHO classification?

Virchows Archiv

相似文献

Virchows Archiv

相关期刊

检索历史清除